210 related articles for article (PubMed ID: 37218754)
1. Recent Genome-Editing Approaches toward Post-Implanted Fetuses in Mice.
Nakamura S; Inada E; Saitoh I; Sato M
BioTech (Basel); 2023 May; 12(2):. PubMed ID: 37218754
[TBL] [Abstract][Full Text] [Related]
2. Transplacental delivery of genome editing components causes mutations in embryonic cardiomyocytes of mid-gestational murine fetuses.
Nakamura S; Ishihara M; Ando N; Watanabe S; Sakurai T; Sato M
IUBMB Life; 2019 Jul; 71(7):835-844. PubMed ID: 30635953
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances and Future Perspectives of In Vivo Targeted Delivery of Genome-Editing Reagents to Germ Cells, Embryos, and Fetuses in Mice.
Sato M; Takabayashi S; Akasaka E; Nakamura S
Cells; 2020 Mar; 9(4):. PubMed ID: 32225003
[TBL] [Abstract][Full Text] [Related]
4. Hydrodynamics-Based Transplacental Delivery as a Useful Noninvasive Tool for Manipulating Fetal Genome.
Nakamura S; Ando N; Watanabe S; Akasaka E; Ishihara M; Sato M
Cells; 2020 Jul; 9(7):. PubMed ID: 32708213
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Production of Genome-Edited Rats.
Sato M; Nakamura S; Inada E; Takabayashi S
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691
[TBL] [Abstract][Full Text] [Related]
7. Successful
Takabayashi S; Iijima K; Tsujimura M; Aoshima T; Takagi H; Aoto K; Sato M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142589
[TBL] [Abstract][Full Text] [Related]
8. Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice.
Sato M; Miyagasako R; Takabayashi S; Ohtsuka M; Hatada I; Horii T
Cells; 2020 Feb; 9(3):. PubMed ID: 32110989
[TBL] [Abstract][Full Text] [Related]
9. Transplacental Gene Delivery (TPGD) as a Noninvasive Tool for Fetal Gene Manipulation in Mice.
Nakamura S; Watanabe S; Ando N; Ishihara M; Sato M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775372
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
[TBL] [Abstract][Full Text] [Related]
11. In vivo genome editing targeted towards the female reproductive system.
Sato M; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Gurumurthy CB
Arch Pharm Res; 2018 Sep; 41(9):898-910. PubMed ID: 29974342
[TBL] [Abstract][Full Text] [Related]
12. Electroporation-mediated genome editing in vitrified/warmed mouse zygotes created by IVF via ultra-superovulation.
Nakagawa Y; Sakuma T; Takeo T; Nakagata N; Yamamoto T
Exp Anim; 2018 Nov; 67(4):535-543. PubMed ID: 30012936
[TBL] [Abstract][Full Text] [Related]
13. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
15. Electroporation-Mediated Genome Editing of Livestock Zygotes.
Lin JC; Van Eenennaam AL
Front Genet; 2021; 12():648482. PubMed ID: 33927751
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 Endonuclease-Mediated Mouse Genome Editing of One-Cell and/or Two-Cell Embryos by Electroporation, and the Use of Rad51 to Enhance Knock-In Allele Homozygosity via Interhomolog Repair Mechanism.
Garza S; Paik R
Methods Mol Biol; 2023; 2631():253-266. PubMed ID: 36995671
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP
FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558
[TBL] [Abstract][Full Text] [Related]
19. Boosting targeted genome editing using the hei-tag.
Thumberger T; Tavhelidse-Suck T; Gutierrez-Triana JA; Cornean A; Medert R; Welz B; Freichel M; Wittbrodt J
Elife; 2022 Mar; 11():. PubMed ID: 35333175
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new.
Sato M; Ohtsuka M; Watanabe S; Gurumurthy CB
Biol Direct; 2016 Mar; 11(1):16. PubMed ID: 27037013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
